Pharmaceuticals in Turkey

Pharmaceuticals in Turkey


  • Products Id :- OHMF4579
  • |
  • Pages: 38
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pharmaceuticals in Turkey

Summary

Pharmaceuticals in Turkey industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Turkey pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Turkish pharmaceuticals market had total revenues of USD 4.3bn in 2017, representing a compound annual growth rate (CAGR) of 3.7% between 2013 and 2017.

- The Turkish market has huge potential for growth; however, it also faces continued challenges.

- With health issues becoming more exposed, the Turkish population have become increasingly concerned with maintaining their health, which has helped fuel growth in the market.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Turkey

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Turkey

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Turkey pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Turkey pharmaceuticals market by value in 2017?

- What will be the size of the Turkey pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Turkey pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Turkey's pharmaceuticals market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 16

New entrants 17

Threat of substitutes 19

Degree of rivalry 20

Leading Companies 22

Abdi Ibrahim Pharmaceuticals 22

Novartis AG 23

Pfizer Inc. 26

Sanofi SA 30

Macroeconomic Indicators 33

Country data 33

Methodology 35

Industry associations 36

Related MarketLine research 36

Appendix 37

About MarketLine 37

List of Figures

Figure 1: Turkey pharmaceuticals market value: USD billion, 2013-17

Figure 2: Turkey pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Turkey pharmaceuticals market share: % share, by value, 2017

Figure 4: Turkey pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Turkey, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Turkey, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Turkey, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Turkey, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Turkey, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Turkey, 2017

Figure 11: Novartis AG: revenues & profitability

Figure 12: Novartis AG: assets & liabilities

Figure 13: Pfizer Inc.: revenues & profitability

Figure 14: Pfizer Inc.: assets & liabilities

Figure 15: Sanofi SA: revenues & profitability

Figure 16: Sanofi SA: assets & liabilities

List of Tables

Table 1: Turkey pharmaceuticals market value: USD billion, 2013-17

Table 2: Turkey pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Turkey pharmaceuticals market share: % share, by value, 2017

Table 4: Turkey pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Abdi Ibrahim Pharmaceuticals: key facts

Table 6: Novartis AG: key facts

Table 7: Novartis AG: key financials (USD )

Table 8: Novartis AG: key financial ratios

Table 9: Pfizer Inc.: key facts

Table 10: Pfizer Inc.: key financials (USD )

Table 11: Pfizer Inc.: key financial ratios

Table 12: Sanofi SA: key facts

Table 13: Sanofi SA: key financials (USD )

Table 14: Sanofi SA: key financials (EUR)

Table 15: Sanofi SA: key financial ratios

Table 16: Turkey size of population (million), 2013-17

Table 17: Turkey gdp (constant 2005 prices, USD billion), 2013-17

Table 18: Turkey gdp (current prices, USD billion), 2013-17

Table 19: Turkey inflation, 2013-17

Table 20: Turkey consumer price index (absolute), 2013-17

Table 21: Turkey exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 24983
Site License
USD 700 INR 49966
Corporate User License
USD 1050 INR 74949

NEWSLETTER BY CATEGORY




Testimonials

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com